213685-50-8

Usage

Classification

Phenolic amine derivative

Physical appearance

White to yellowish crystalline powder

Primary use

Intermediate in synthesis of various compounds including dyes, pharmaceuticals, and agrochemicals

Properties

Chelating agent
Potential antioxidant and anti-inflammatory properties

Applications

Used in pharmaceutical production
Potential applications in medicine for drug development

Research interest

Studied for its antioxidant and anti-inflammatory properties
Compound of interest in medicinal chemistry

Upstream product

• 213685-59-7 2-nitroresorcinol monobenzyl ether 

Downstream Products

• 213684-78-7 N-(2,6-diisopropylphenyl)-6-((4-hydroxybenzo[d]oxazol-2-yl)thio)hexanamide 
• 213685-52-0 4-(benzyloxy)benzo[d]oxazole-2-thiol 

Relevant academic research and scientific papers

Anilide compounds and drugs containing the same

The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same. The invention relates to a compound represented by the following general formula: represents a divalent residue of benzene with a substituent(s), heterocycle-condensed benzene which may or may not have a substituent, pyridine which may or may not have a substituent, cyclohexane or naphthalene or Ar represents an aryl group which may or may not have a substituent; X represents —NH—, oxygen atom or sulfur atom; Y represents —NR4—, oxygen atom, sulfur atom, sulfoxide or sulfone; Z represents single bond or —NR5—; R4represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; R5represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; and n represents an integer of 0 to 15. The inventive compounds are useful in the form of pharmaceutical composition, specifically as acyl coenzyme A cholesterol acyltransferase (ACAT) inhibitor.